Status:
COMPLETED
Clinical Patterns of Neuromyelitis Optica Spectrum Disorders in Assiut University Hospital
Lead Sponsor:
Assiut University
Conditions:
Neuromyelitis Optica Spectrum Disorder
Eligibility:
All Genders
3-75 years
Brief Summary
Neuromyelitis Optica Spectrum Disorders (NMOSD) are a group of inflammatory demyelinating disorders of the central nervous system. Although NMOSD occurs much more commonly in nations with a predominat...
Detailed Description
Neuromyelitis Optica Spectrum Disorders (NMOSD) are a group of inflammatory demyelinating disorders of the central nervous system characterized by episodes of immune-mediated demyelination and axonal ...
Eligibility Criteria
Inclusion
- All cases that fulfill the international 2015 consensus criteria of NMOSD
- Any episode suggestive of idiopathic inflammatory demyelinating central nervous system disease including
- longitudinally extensive transverse myelitis (LETM) or optic neuritis (ON) plus Cerebral or Brainstem syndrome (LETM or ON PLUS)
- optic neuritis (ON)
- longitudinally extensive transverse myelitis (LETM),
- Transverse myelitis with non-extensive lesion (NETM)
- Acute encephalomyelitis (ADEM).
- Atypical MS cases (atypical clinical presentation, course, radiological findings or atypical response to treatment)
- Age: all patients of both sexes and all age groups will be included.
Exclusion
- Inclusion criteria for suspected NMOSD were not met
- An alternate diagnosis became apparent
- if no serum sample was supplied
- Subject declined to provide written informed consent.
Key Trial Info
Start Date :
February 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03819413
Start Date
February 15 2019
End Date
August 30 2020
Last Update
November 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospital
Asyut, Egypt, 71511